Clinical Trials in Cleveland

Showing 1341-1360 of 16,969 trials

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

NCT07454174

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Richard Fatica20 participantsStarted Feb 2026

Cleveland, Ohio, United States

COMPLETEDPhase 3< 1 mile

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

NCT00936390

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells. Androgen-deprivation therapy may lessen the amount of androgens made by the body. It is not yet known whether radiation therapy is more effective with or without androgen-deprivation therapy in treating patients with prostate cancer. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared with radiation therapy given together with androgen-deprivation therapy in treating patients with prostate cancer.

Prostate Cancer

Radiation Therapy Oncology Group1,538 participantsStarted Sep 2009

Birmingham, Alabama, United States • Fairbanks, Alaska, United States • Peoria, Arizona, United States +515 more locations

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Find Trials by Condition in Cleveland

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

Feasibility of Neural Feedback for Lower Limb Amputees

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Deep Functional Phenotyping of the ALA Lung Health Cohort

A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA